One Size Fits None: Patient Journeys in HR+/HER2- Metastatic Breast Cancer With CDK4/6 Inhibitors

One Size Fits None: Patient Journeys in HR+/HER2- Metastatic Breast Cancer With CDK4/6 Inhibitors Hybrid Event WEDNESDAY, 6 MAY 2026 I 11:00 - 12:00 CEST I 60 MIN Hamburg Hall, Messe Berlin, Berlin, Germany This symposium offers an in-depth review of clinical cases with comprehensive discussion from our panel of renowned international experts, Drs Thill, Cottu, and Mahtani. The programme, focusing on treatment with CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer, is designed to be engaging with individualisation of care at its core. The audience will also have the opportunity to submit questions and engage with the panel directly. Join this symposium to gain practical insights and learn from the experience of leading specialists in the field. Please note, you will need to be a registered attendee of the ESMO Breast Cancer Annual Conference in order to participate.